Envarsus PA · DIN 02485877 · 0.75 mg · extended release tablet
Limited Use, Reason for Use code 590 requiredMarketed · checked November 17, 2026
StatusLimited Use, Reason for Use code 590 required
Write on scriptReason for Use code 590 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 590
Reason for Use code 590
For the prophylaxis of organ rejection in allogenic kidney or liver transplant adult patients in combination with other immunosuppressants.
Coverage limit:
LU Authorization Period: Indefinite
No interchangeable product listed in the Ontario extract
Envarsus PA · DIN 02485877
Manufacturer: Endo Ventures Ltd.; listing date 2020-09-30
Health Canada: Marketed since 2026-03-23 · brand ENVARSUS PA · ATC L04AD02 TACROLIMUS · form Tablet (extended-release) · route Oral · ingredients TACROLIMUS 0.75 MG · company Knight therapeutics inc. · schedule Prescription
Envarsus PA: Formulary list price $2.10 per unit (the source does not state the unit; exact figure $2.0999). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02485877)
Source record
DIN 02485877: Envarsus PA
Raw flags: sec12=Y, sec3=Y
Item: 924400008; group id 1051; item number 2407; lccId 00340; manufacturer id EVL
Source form: ER Tab; strength: 0.75mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $2.0999; ministry $2.0999
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02485877
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=97609
Shortage status: not checked (no credentials)